ATHE Presents Phase 2 ATH434 Data, Plans Phase 3 in Multiple System Atrophy, Reports Statistically Significant Slowing of Disease Progression
Alterity Therapeutics Limited American Depositary Shares · Now $4.02
-3.5% in 7d after detection
Post-detection moves
1h
—
1d
0.0%
3d
-3.0%
7d
-3.5%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS